The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

Duromine     2-methyl-1-phenyl-propan-2- amine

Synonyms: Ionamine, Lipopill, Obermine, Phentrol, Inoamin, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Phentermine hydrochloride


Psychiatry related information on Phentermine hydrochloride


High impact information on Phentermine hydrochloride


Chemical compound and disease context of Phentermine hydrochloride


Biological context of Phentermine hydrochloride


Anatomical context of Phentermine hydrochloride


Associations of Phentermine hydrochloride with other chemical compounds


Gene context of Phentermine hydrochloride


Analytical, diagnostic and therapeutic context of Phentermine hydrochloride


  1. Psychological treatment of obesity with phentermine resin as an adjunct. Roberts, C.R. The American journal of psychiatry. (1978) [Pubmed]
  2. Appetite suppressants and valvular heart disease in a population-based sample: the HyperGEN study. Palmieri, V., Arnett, D.K., Roman, M.J., Liu, J.E., Bella, J.N., Oberman, A., Kitzman, D.W., Hopkins, P.N., Morgan, D., de Simone, G., Devereux, R.B. Am. J. Med. (2002) [Pubmed]
  3. Pharmacologic induction of weight loss to treat type 2 diabetes. Redmon, J.B., Raatz, S.K., Kwong, C.A., Swanson, J.E., Thomas, W., Bantle, J.P. Diabetes Care (1999) [Pubmed]
  4. Valvular heart disease in fenfluramine- phentermine-treated patients: a comparison with control patients. Wadden, T.A., Silvestry, F.E., Aber, J.L., Berkowitz, R.I., Foster, G.D., Sutton, M.G. Obes. Res. (1999) [Pubmed]
  5. Long-term weight control study. IV (weeks 156 to 190). The second double-blind phase. Weintraub, M., Sundaresan, P.R., Schuster, B., Averbuch, M., Stein, E.C., Cox, C., Byrne, L. Clin. Pharmacol. Ther. (1992) [Pubmed]
  6. Pharmacotherapy for obesity. Ioannides-Demos, L.L., Proietto, J., McNeil, J.J. Drugs (2005) [Pubmed]
  7. Evaluation of phentermine and fenfluramine, alone and in combination, in normal, healthy volunteers. Brauer, L.H., Johanson, C.E., Schuster, C.R., Rothman, R.B., de Wit, H. Neuropsychopharmacology (1996) [Pubmed]
  8. Smoking cessation in a patient being treated with fenfluramine plus phentermine for simple obesity. Rothman, R.B. The Journal of clinical psychiatry. (1996) [Pubmed]
  9. Alterations in alcohol consumption, withdrawal seizures, and monoamine transmission in rats treated with phentermine and 5-hydroxy-L-tryptophan. Halladay, A.K., Wagner, G.C., Sekowski, A., Rothman, R.B., Baumann, M.H., Fisher, H. Synapse (2006) [Pubmed]
  10. A population-based study of appetite-suppressant drugs and the risk of cardiac-valve regurgitation. Jick, H., Vasilakis, C., Weinrauch, L.A., Meier, C.R., Jick, S.S., Derby, L.E. N. Engl. J. Med. (1998) [Pubmed]
  11. Valvular heart disease associated with fenfluramine-phentermine. Connolly, H.M., Crary, J.L., McGoon, M.D., Hensrud, D.D., Edwards, B.S., Edwards, W.D., Schaff, H.V. N. Engl. J. Med. (1997) [Pubmed]
  12. The contribution of increased thermogenesis to the effect of anorectic drugs on body composition in mice. Arch, J.R. Am. J. Clin. Nutr. (1981) [Pubmed]
  13. Fluoxetine increases the anorectic and long-term dopamine-depleting effects of phentermine. Callahan, B.T., Yuan, J., Ricaurte, G.A. Synapse (2000) [Pubmed]
  14. Phentermine+fenfluramine produce cocaine-like discriminative cues. Schechter, M.D., McBurney, D. Life Sci. (1996) [Pubmed]
  15. An update on the pharmacological treatment of obesity. Schnee, D.M., Zaiken, K., McCloskey, W.W. Current medical research and opinion. (2006) [Pubmed]
  16. Effects of prenatal co-administration of phentermine and dexfenfluramine in rats. Bratter, J., Gessner, I.H., Rowland, N.E. Eur. J. Pharmacol. (1999) [Pubmed]
  17. Detailed examination of fenfluramine-phentermine users with valve abnormalities identified in Fargo, North Dakota. Kimmel, S.E., Keane, M.G., Crary, J.L., Jones, J., Kinman, J.L., Beare, J., Sammel, M., Sutton, M.S., Strom, B.L. Am. J. Cardiol. (1999) [Pubmed]
  18. Synergistic interactions between fenfluramine and phentermine. Wellman, P.J., Maher, T.J. Int. J. Obes. Relat. Metab. Disord. (1999) [Pubmed]
  19. Effects of phentermine and phenformin on biomarkers of aging in rats. Anisimov, V.N., Ukraintseva, S.V., Anikin, I.V., Popovich, I.G., Zabezhinski, M.A., Bertsein, L.M., Arutjunyan, A.V., Ingram, D.K., Lane, M.A., Roth, G.S. Gerontology. (2005) [Pubmed]
  20. Pregnancy outcomes after first trimester exposure to phentermine/fenfluramine. Jones, K.L., Johnson, K.A., Dick, L.M., Felix, R.J., Kao, K.K., Chambers, C.D. Teratology (2002) [Pubmed]
  21. The N-hydroxylation of phentermine by rat liver microsomes. Sum, C.Y., Cho, A.K. Drug Metab. Dispos. (1977) [Pubmed]
  22. Noradrenergic and dopaminergic effects of (+)-amphetamine-like stimulants in the baboon Papio anubis. Alexander, M., Rothman, R.B., Baumann, M.H., Endres, C.J., Brasić, J.R., Wong, D.F. Synapse (2005) [Pubmed]
  23. The metabolism of N-hydroxyphentermine by rat liver microsomes. Sum, C.Y., Cho, A.K. Drug Metab. Dispos. (1979) [Pubmed]
  24. Effects on serotonin in rat hypothalamus of D-fenfluramine, aminorex, phentermine and fluoxetine. Tao, R., Fray, A., Aspley, S., Brammer, R., Heal, D., Auerbach, S. Eur. J. Pharmacol. (2002) [Pubmed]
  25. Treatment of a 4-year-old boy with ADHD with the dopamine releaser phentermine. Rothman, R.B. The Journal of clinical psychiatry. (1996) [Pubmed]
  26. Appetite suppressant drugs as inhibitors of human cytochromes P450: in vitro inhibition of P450-2D6 by D- and L-fenfluramine, but not phentermine. von Moltke, L.L., Greenblatt, D.J., Ciraulo, D.A., Grassi, J.M., Granda, B.W., Duan, S.X., Harmatz, J.S., Shader, R.I. Journal of clinical psychopharmacology. (1998) [Pubmed]
  27. Effects of dopamine and serotonin-releasing agents on methamphetamine discrimination and self-administration in rats. Munzar, P., Baumann, M.H., Shoaib, M., Goldberg, S.R. Psychopharmacology (Berl.) (1999) [Pubmed]
  28. Behavioural and neurochemical characteristics of phentermine and fenfluramine administered separately and as a mixture in rats. Shoaib, M., Baumann, M.H., Rothman, R.B., Goldberg, S.R., Schindler, C.W. Psychopharmacology (Berl.) (1997) [Pubmed]
  29. Studies on the persistence of basic amines in the rabbit lung. Wilson, A.G., Pickett, R.D., Eling, T.E., Anderson, M.W. Drug Metab. Dispos. (1979) [Pubmed]
  30. Phentermine inhibition of recombinant human liver monoamine oxidases A and B. Nandigama, R.K., Newton-Vinson, P., Edmondson, D.E. Biochem. Pharmacol. (2002) [Pubmed]
  31. Characterization of phentermine and related compounds as monoamine oxidase (MAO) inhibitors. Ulus, I.H., Maher, T.J., Wurtman, R.J. Biochem. Pharmacol. (2000) [Pubmed]
  32. Effects of phentermine and cocaine on fenfluramine-induced depletion of serotonin in mouse brain. Baumann, M.H., Schuster, C.R., Rothman, R.B. Drug and alcohol dependence. (1996) [Pubmed]
  33. Autopsy findings of heart and lungs in a patient with primary pulmonary hypertension associated with use of fenfluramine and phentermine. Tomita, T., Zhao, Q. Chest (2002) [Pubmed]
  34. Long-term weight control study. I (weeks 0 to 34). The enhancement of behavior modification, caloric restriction, and exercise by fenfluramine plus phentermine versus placebo. Weintraub, M., Sundaresan, P.R., Madan, M., Schuster, B., Balder, A., Lasagna, L., Cox, C. Clin. Pharmacol. Ther. (1992) [Pubmed]
  35. Phentermine self-administration in naive free-feeding and food-deprived rats: a dose response study. Papasava, M., Singer, G., Papasava, C.L. Psychopharmacology (Berl.) (1985) [Pubmed]
  36. Lifestyle modification in the pharmacologic treatment of obesity: a pilot investigation of a potential primary care approach. Wadden, T.A., Berkowitz, R.I., Vogt, R.A., Steen, S.N., Stunkard, A.J., Foster, G.D. Obes. Res. (1997) [Pubmed]
  37. Gas-liquid chromatographic determination of phentermine in human plasma following oral administration to healthy subjects. Dadgar, D., Climax, J., Lambe, R., Darragh, A. J. Chromatogr. (1985) [Pubmed]
WikiGenes - Universities